SZSE ChiNext
Every company in the roster listed on SZSE ChiNext.
Every company in the roster listed on SZSE ChiNext.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Betta Pharmaceuticals Co.300558 · SZSE ChiNext | 9 assets: 1 approved, 3 Ph 3, 3 Ph 2, 2 Ph 1 | BefotertinibPhase 3 · Non-Small Cell Lung CancerPartial signal | Dec 2026BPI-371153 · Phase 1 | — | — | Profitable | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.